医学
血糖性
低血糖
糖尿病
预期寿命
内科学
重症监护医学
升糖指数
作者
Yoshiki Kusunoki,Kosuke Konishi,Taku Tsunoda,Hidenori Koyama
出处
期刊:Internal Medicine
[The Japanese Society of Internal Medicine]
日期:2021-09-17
卷期号:61 (3): 281-290
被引量:38
标识
DOI:10.2169/internalmedicine.8424-21
摘要
The goal of diabetes treatment is to maintain good glycemic control, prevent the development and progression of diabetic complications, and ensure the same quality of life and life expectancy as healthy people. Hemoglobin A1c (HbA1c) is used as an index of glycemic control, but strict glycemic control using HbA1c as an index may lead to severe hypoglycemia and cardiovascular death. Glycemic variability (GV), such as excessive hyperglycemia and hypoglycemia, is associated with diabetic vascular complications and has been recognized as an important index of glycemic control. Here, we reviewed the definition and evaluated the clinical usefulness of GV, and its relationship with diabetic complications and therapeutic strategies to reduce GV.
科研通智能强力驱动
Strongly Powered by AbleSci AI